Last reviewed · How we verify
Epicondylitis
Approved treatments
- Cortone
- Decadron · Generic (originally Merck)
- prednison · Wen Zhang
- Medrol · Generic (originally Upjohn/Pfizer)
Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions. - Rodinolone
- Deltasone · Generic (originally Schering)
- Betametasone
Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system. - Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
- Methylprednisolon · Leiden University Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Epicondylitis patent landscape — cliff calendar, originator estates, attackable patents
- Epicondylitis treatment landscape brief
- Epicondylitis treatment updates RSS
Frequently asked questions about Epicondylitis
What drugs treat Epicondylitis?
Tracked treatments include Cortone, Decadron, prednison, Medrol, Rodinolone, Deltasone, Betametasone, Prelone.
What is the treatment for Epicondylitis?
Standard treatment for Epicondylitis includes Cortone, Decadron, prednison, Medrol, Rodinolone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Epicondylitis patent cliff · Epicondylitis CI report
- Treatment: Cortone
- Treatment: Decadron · Generic (originally Merck)
- Treatment: prednison · Wen Zhang
- Treatment: Medrol · Generic (originally Upjohn/Pfizer)
- Treatment: Rodinolone
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing